Cargando…
Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways
Autores principales: | Yang, Jianhong, Pei, Heying, Luo, Hong, Fu, Afu, Yang, Hansuo, Hu, Jia, Zhao, Chengjian, Chai, LuLu, Chen, Xiang, Shao, Ximing, Wang, Chunyu, Wu, Wenshuang, Wan, Li, Ye, Haoyu, Qiu, Qiang, Peng, Aihua, Wei, Yuquan, Yang, Li, Chen, Lijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476731/ https://www.ncbi.nlm.nih.gov/pubmed/32934777 http://dx.doi.org/10.18632/oncotarget.27369 |
Ejemplares similares
-
Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways
por: Yang, Jianhong, et al.
Publicado: (2016) -
Honokiol Ameliorates Post-Myocardial Infarction Heart Failure Through Ucp3-Mediated Reactive Oxygen Species Inhibition
por: Liu, Jianyu, et al.
Publicado: (2022) -
Corrigendum: Honokiol ameliorates post-myocardial infarction heart failure through Ucp3-mediated reactive oxygen species inhibition
por: Liu, Jianyu, et al.
Publicado: (2022) -
HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma
por: Zhang, Xiangxiang, et al.
Publicado: (2022) -
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
por: Song, Jung Min, et al.
Publicado: (2016)